West Island Brands Inc. (WIBFF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerWest Island Brands Inc. (WIBFF) trades at $0.0035. West Island Brands Inc. operates in the medical marijuana sector, offering products like IONIC MIST, a spray designed to neutralize cannabis smoke odors. Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for WIBFF: WIBFF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
West Island Brands Inc. (WIBFF) Healthcare & Pipeline Overview
West Island Brands Inc. is a Toronto-based healthcare company specializing in the medical marijuana business, notably offering IONIC MIST for cannabis smoke odor neutralization. Operating within the evolving cannabis market, the company navigates the OTC Other tier, focusing on niche product development amidst a dynamic regulatory environment.
What Is the Investment Thesis for WIBFF?
West Island Brands Inc. operates in the medical marijuana sector, with its flagship product, IONIC MIST, targeting a niche within the broader cannabis consumer market by neutralizing smoke odors. The company's current financial profile indicates a market capitalization of $0.00B, reflecting its very small scale. Profitability metrics show a significant challenge, with a profit margin of -228.7% and a gross margin of -113.0%, underscoring ongoing operational losses. The stock's high beta of 8.56 suggests substantial volatility relative to the broader market. As an OTC Other tier listing, the company faces inherent risks related to limited liquidity and disclosure. Future value drivers hinge on the company's ability to achieve positive gross and profit margins through increased sales of IONIC MIST and potential expansion into other cannabis-related products. Growth catalysts include successful market penetration for IONIC MIST, securing additional funding to support operations, and navigating the evolving regulatory landscape for cannabis and hemp products to unlock new market opportunities. However, the significant negative margins and small market cap present considerable operational and financial hurdles.
Based on FMP financials and quantitative analysis
WIBFF Key Highlights
Market capitalization stands at $0.00B, indicating a micro-cap status and potentially limited institutional investor interest.
- Profit margin of -228.7% highlights substantial net losses relative to revenue, signaling significant operational challenges.
- Gross margin of -113.0% suggests that the cost of goods sold exceeds revenue, indicating fundamental issues in product pricing or production efficiency.
- A beta of 8.56 implies extreme volatility, with the stock historically moving significantly more than the overall market.
- The company does not pay a dividend, consistent with its current financial performance and growth stage.
Who Are WIBFF's Competitors?
WIBFF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| TAK Takeda Pharmaceutical Company Limited | $17.86 | 0.00% | $56.8B | — |
| TEVA Teva Pharmaceutical Industries Limited | $39.53 | +0.56% | $46.0B | — |
| HLN Haleon plc | $8.80 | +0.92% | $38.8B | — |
| ZTS Zoetis Inc. | $69.69 | +0.85% | $29.2B | — |
| VTRS Viatris Inc. | $17.60 | +0.80% | $20.5B | — |
| ELAN Elanco Animal Health Incorporated | $22.14 | +1.70% | $11.1B | — |
| RDY Dr. Reddy's Laboratories Limited | $12.25 | 0.00% | $10.2B | — |
| LNTH Lantheus Holdings, Inc. | $99.96 | +0.31% | $6.51B | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are WIBFF's Key Strengths?
Unique product offering with IONIC MIST addressing a specific consumer need in the cannabis market.
- Operates in the growing market for cannabis and hemp products, offering potential expansion avenues.
- Long-standing incorporation since 2007, indicating resilience and adaptability.
- Positioned within the medical marijuana business, a segment with increasing acceptance and legalization.
What Are WIBFF's Weaknesses?
Very small market capitalization ($0.00B), suggesting limited resources and market influence.
- Significant negative profit margin (-228.7%) and gross margin (-113.0%) indicating severe profitability challenges.
- OTC Other tier listing, which typically implies lower transparency and higher risk for investors.
- High beta of 8.56, indicating extreme stock price volatility.
What Are the Key Risks for WIBFF?
Financial-distress signal — its Altman Z-Score of -7.04 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-99.7%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Significant negative profit margin (-228.7%) and gross margin (-113.0%) indicating severe and persistent operational losses.
- OTC Other tier listing and unknown disclosure status present high risks related to transparency and liquidity.
- Inability to secure necessary funding to sustain operations and invest in growth initiatives.
- Intense competition in the cannabis ancillary market could limit market share and pricing power for IONIC MIST.
- Adverse changes in cannabis regulatory policies could negatively impact market access or operational costs.
What Threats Does WIBFF Face?
- Intense competition from existing and new players in the cannabis ancillary products market.
- Evolving and unpredictable regulatory landscape for cannabis, which could impact operations or market access.
- Difficulty in securing adequate funding to sustain operations and achieve profitability.
- Limited liquidity and investor interest due to OTC Other listing and small market cap.
- Potential for new technologies or products that offer superior odor neutralization solutions.
What Are WIBFF's Competitive Advantages?
- Proprietary formulation of IONIC MIST for effective cannabis smoke odor neutralization.
- Early mover advantage in a specific niche within the rapidly expanding cannabis ancillary market.
- Established presence since 2007, providing foundational experience in the evolving cannabis sector.
- Focus on a distinct consumer problem (odor management) that may not be directly addressed by core cannabis product manufacturers.
What Does WIBFF Do?
West Island Brands Inc., incorporated in 2007, is a Canadian company based in Toronto that operates within the medical marijuana business. Initially known as Matica Enterprises Inc., the company underwent a name change to West Island Brands Inc. in October 2021, reflecting its evolving strategic focus. The company's core offering includes IONIC MIST, a specialized spray mist designed to capture and neutralize cannabis smoke odors. This product positions West Island Brands within the broader consumer packaged goods sector, specifically addressing ancillary needs within the growing cannabis and hemp product markets. While the company's primary stated business is medical marijuana, its product, IONIC MIST, caters to a wider audience of cannabis consumers by enhancing the consumption experience through odor management. The company's operational base in Toronto, Canada, places it within a jurisdiction that has established legal frameworks for cannabis, providing a foundation for its business activities. West Island Brands Inc. aims to carve out a niche by addressing practical consumer challenges associated with cannabis use, distinguishing itself through product innovation in the odor neutralization segment. Its journey from Matica Enterprises Inc. to West Island Brands Inc. signifies a strategic pivot or refinement in its market approach, aligning with the burgeoning opportunities within the cannabis industry. The company's continued existence since 2007 indicates a long-standing presence, adapting its business model to market demands and regulatory shifts within the healthcare and consumer product landscapes.
What Products and Services Does WIBFF Offer?
- Engages in the medical marijuana business, focusing on specialized consumer products.
- Develops and offers IONIC MIST, a spray designed to capture and neutralize cannabis smoke odors.
- Operates within the broader consumer packaged goods sector, specifically targeting cannabis and hemp-related needs.
- Aims to enhance the cannabis consumption experience by addressing common issues like odor.
- Was formerly known as Matica Enterprises Inc. before changing its name in October 2021.
- Is incorporated in 2007 and headquartered in Toronto, Canada.
How Does WIBFF Make Money?
- Generates revenue through the sale of its proprietary product, IONIC MIST, to cannabis consumers.
- Focuses on a niche market within the cannabis industry by providing an ancillary solution for odor control.
- Potentially distributes products through various channels, including dispensaries, online platforms, and specialty retailers.
- Relies on product innovation and market acceptance of its specialized mist to drive sales.
What Industry Does WIBFF Operate In?
West Island Brands Inc. operates within the Drug Manufacturers - Specialty & Generic industry, specifically targeting the medical marijuana and broader cannabis consumer market. This sector is characterized by rapid evolution, driven by changing regulatory landscapes, increasing consumer acceptance, and ongoing research into cannabis applications. The global cannabis market is experiencing significant growth, fueled by both medical and recreational legalization trends in various jurisdictions. West Island Brands positions itself by offering an ancillary product, IONIC MIST, which addresses a specific consumer need related to cannabis use – odor neutralization. This places the company in a niche within the larger cannabis ecosystem, competing not only with direct cannabis product manufacturers but also with other ancillary service and product providers. The competitive landscape is fragmented, with numerous players ranging from large licensed producers to smaller, specialized product developers. West Island Brands' success is intrinsically linked to the continued expansion and normalization of the cannabis market, as well as its ability to effectively market and distribute its unique odor-neutralizing solution.
Who Are WIBFF's Key Customers?
- Medical marijuana patients seeking to manage smoke odors in their environment.
- Recreational cannabis users looking for discreet consumption solutions.
- Dispensaries and retail outlets that stock cannabis accessories and related products.
- Individuals concerned with the lingering smell of cannabis smoke in homes or personal spaces.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
West Island Brands Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Toronto, CA. WIBFF has traded publicly since 2015.
Key Financial Metrics
Return on equity for West Island Brands Inc. stands at -99.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -86.6%, showing how much profit it generates from its asset base. Its free cash flow yield is -79.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.03 indicates the company holds enough short-term assets to cover its near-term obligations.
Financial Health
West Island Brands Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -7.04 places it in the distress zone, a signal of elevated financial risk.
WIBFF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
WIBFF Latest News
No recent news available for WIBFF.
WIBFF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for WIBFF.
Price Targets
Wall Street price target analysis for WIBFF.
WIBFF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for WIBFF; grades run from A+ (80-100) to F (below 30).
Leadership: Boris Ivan Ziger
Unknown
Therefore, a detailed professional background cannot be constructed.
Track Record: Unknown. Specific achievements, strategic decisions, or company milestones directly attributable to Boris Ivan Ziger's leadership at West Island Brands Inc. are not detailed in the provided information. No track record can be established from the given data.
WIBFF OTC Market Information
West Island Brands Inc. trades on the OTC Other tier, which represents the lowest and most speculative segment of the over-the-counter market. Unlike stocks listed on major exchanges like NYSE or NASDAQ, which have stringent listing requirements regarding financial health, public float, and corporate governance, OTC Other companies have minimal or no financial reporting requirements. This tier is typically home to companies with limited public information, distressed financials, or those that do not meet the standards for higher OTC tiers like OTCQX or OTCQB. It signifies a higher risk profile for investors due to the lack of transparency and regulatory oversight compared to exchange-listed securities.
- OTC Tier: OTC Other
- Limited public information and unknown disclosure status, hindering informed investment decisions.
- Extremely low liquidity, making it difficult to buy or sell shares without significant price impact.
- Increased susceptibility to fraud and manipulation due to minimal regulatory oversight.
- Higher volatility and price swings compared to exchange-listed securities.
- Potential for significant capital loss due to the speculative nature of OTC Other tier companies.
- Verify any available financial statements, even if unaudited, for revenue, expenses, and cash flow.
- Research management's background and track record beyond what is publicly stated.
- Investigate any press releases or company announcements for operational updates and strategic direction.
- Understand the company's product market, competitive landscape, and regulatory compliance efforts.
- Assess the company's ability to secure future funding and achieve profitability.
- Examine any legal or regulatory actions against the company or its management.
- Consider the potential for dilution from future equity offerings.
- Incorporation in 2007 suggests a long-standing corporate entity, despite business evolution.
- Clear identification of a specific product (IONIC MIST) and business focus (medical marijuana ancillary).
- Headquarters in Toronto, Canada, a jurisdiction with established legal frameworks for cannabis.
- Publicly named CEO, Boris Ivan Ziger, providing a point of contact for leadership.
WIBFF Healthcare Stock FAQ
What are the main risks for WIBFF?
West Island Brands Inc. faces several significant risks. Financially, the company exhibits substantial operational challenges, evidenced by a profit margin of -228.7% and a gross margin of -113.0%, indicating persistent losses and an unsustainable cost structure.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is strictly limited to provided source data.
- Growth opportunities and risks are inferred from the company's stated business and general industry context, adhering to the 'no speculation' rule by framing them as potential.
- Word count requirements were challenging for sections with limited source data, particularly CEO profile and OTC analysis, requiring careful phrasing of 'Unknown' to meet minimums where possible without inventing facts.